Galectin Therapeutics Inc(GALT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GALT Galectin Therapeutics Inc

休市中 12-19 16:00:00 EST

4.38

-1.78

-28.90%

盘后4.24

-0.14-3.20%

19:59 EST

最高4.83	最低3.80	成交量412.15万
今开4.64	昨收6.16	日振幅16.72%
总市值2.82亿	流通市值1.97亿	总股本6,447万
成交额1,760万	换手率9.17%	流通股本4,493万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GALT","market":"US","secType":"STK","nameCN":"Galectin Therapeutics Inc","latestPrice":4.38,"timestamp":1766178000000,"preClose":6.16,"halted":0,"volume":4121482,"hourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.38,"latestTime":"19:59 EST","volume":19443,"amount":82377.3646,"timestamp":1766192393717},"delay":0,"floatShares":44925282,"shares":64472792,"eps":-0.59053,"marketStatus":"休市中","change":-1.78,"latestTime":"12-19 16:00:00 EST","open":4.64,"high":4.83,"low":3.8,"amount":17597557.639112,"amplitude":0.167208,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.59053,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1063166400000,"exchange":"NASDAQ","adjPreClose":6.16,"preHourTrading":{"tag":"盘前","latestPrice":4.61,"preClose":6.16,"latestTime":"09:29 EST","volume":475533,"amount":2058604.231518,"timestamp":1766154599095},"postHourTrading":{"tag":"盘后","latestPrice":4.24,"preClose":4.38,"latestTime":"19:59 EST","volume":19443,"amount":82377.3646,"timestamp":1766192393717},"volumeRatio":6.110257003307513,"impliedVol":2.7809,"impliedVolPercentile":0.908},"requestUrl":"/m/hq/s/GALT","defaultTab":"news","newsList":[{"id":"1198499096","title":"Galectin Therapeutics 发布FDA书面回复后的监管更新，并宣布Richard E. Uihlein提供额外1000万美元的信用额度，足以覆盖至2027年3月的预期支出","url":"https://stock-news.laohu8.com/highlight/detail?id=1198499096","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198499096?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:03","pubTimestamp":1766149396,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics 发布FDA书面回复后的监管更新，并宣布Richard E. Uihlein提供额外1000万美元的信用额度，足以覆盖至2027年3月的预期支出","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GALT","BK4139"],"gpt_icon":0},{"id":"1121035180","title":"Galectin Therapeutics公布2025年9月30日季度财务业绩及业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1121035180","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121035180?lang=zh_cn&edition=full","pubTime":"2025-11-14 21:01","pubTimestamp":1763125281,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics公布2025年9月30日季度财务业绩及业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"1166637116","title":"Galectin Therapeutics在2025年美国肝脏疾病研究协会年会上展示Navigate试验结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1166637116","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166637116?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:03","pubTimestamp":1762779797,"startTime":"0","endTime":"0","summary":"Galectin Therapeutics在2025年美国肝脏疾病研究协会年会上展示了Navigate试验的结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GALT"],"gpt_icon":0},{"id":"2581387238","title":"Galectin Therapeutics Inc.盘中异动 早盘股价大跌5.65%报5.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581387238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581387238?lang=zh_cn&edition=full","pubTime":"2025-11-07 23:29","pubTimestamp":1762529375,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日23时29分，Galectin Therapeutics Inc.股票出现波动，股价快速下挫5.65%。截至发稿，该股报5.27美元/股，成交量6.2723万股，换手率0.10%，振幅6.63%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Metavia Inc.、Puma Biotechnology Inc涨幅较大，Metavia Inc.、Tharimmune, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为131.02%、64.83%、22.40%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为70.00%、37.11%、33.73%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110723293694f5ffc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110723293694f5ffc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GALT","BK4007","BK4539"],"gpt_icon":0},{"id":"2558665729","title":"Galectin Therapeutics Inc.盘中异动 快速下跌5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665729?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:00","pubTimestamp":1754920850,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时00分，Galectin Therapeutics Inc.股票出现波动，股价快速跳水5.55%。截至发稿，该股报3.92美元/股，成交量6.3883万股，换手率0.10%，振幅7.23%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为3523.20%、300.95%、85.58%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为74.27%、70.68%、30.00%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122005094dccace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122005094dccace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","GALT","LENZ","BK4007"],"gpt_icon":0},{"id":"2556327098","title":"Galectin Therapeutics Inc.盘中异动 急速拉升5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556327098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556327098?lang=zh_cn&edition=full","pubTime":"2025-08-01 00:04","pubTimestamp":1753977848,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时04分，Galectin Therapeutics Inc.股票出现波动，股价快速上涨5.39%。截至发稿，该股报3.79美元/股，成交量18.9509万股，换手率0.30%，振幅8.01%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.84%。其相关个股中，Soligenix, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.涨幅较大，Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃，换手率分别为8983.30%、4974.19%、4760.29%，振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为297.60%、97.88%、97.44%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801000408972a9a30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801000408972a9a30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","GALT","BK4139","LENZ"],"gpt_icon":0},{"id":"2555065980","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555065980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555065980?lang=zh_cn&edition=full","pubTime":"2025-07-30 02:16","pubTimestamp":1753812985,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日02时16分，Galectin Therapeutics Inc.股票出现异动，股价快速拉升5.21%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Salarius Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5529.56%、3966.44%、1779.74%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为176.76%、111.54%、75.60%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730021625a46a129d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730021625a46a129d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT","BK4539","BK4007"],"gpt_icon":0},{"id":"2554708649","title":"Galectin Therapeutics Inc.盘中异动 快速拉升5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554708649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554708649?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:05","pubTimestamp":1753715117,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时05分，Galectin Therapeutics Inc.股票出现异动，股价急速上涨5.84%。截至发稿，该股报3.08美元/股，成交量11.5727万股，换手率0.18%，振幅5.50%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Celcuity Inc.、Abpro Holdings, Inc、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为409.25%、202.18%、119.75%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为118.94%、82.93%、75.48%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823051794bf915e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823051794bf915e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","GALT","BK4007","LENZ"],"gpt_icon":0},{"id":"2551214116","title":"Galectin Therapeutics Inc.7月15日成交额为117.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551214116","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551214116?lang=zh_cn&edition=full","pubTime":"2025-07-16 10:14","pubTimestamp":1752632087,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，Galectin Therapeutics Inc.成交额为117.14万美元，成交额较昨日减少14.60%，当日成交量为40.70万股。Galectin Therapeutics Inc.于2025年7月15日跌1.75%，报2.8美元，该股过去5个交易日涨33.97%，年初至今涨117.05%，过去60日涨104.38%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-15|117.14万|-14.60%|40.70万|#|2025-07-14|137.18万|37.79%|50.95万|#|2025-07-11|99.56万|-7.86%|39.21万|#|2025-07-10|108.05万|89.57%|46.17万|#|2025-07-09|57.00万|30.65%|26.16万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716101455a6ac4ca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716101455a6ac4ca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","GALT","BK4007","LENZ"],"gpt_icon":0},{"id":"2551413760","title":"Galectin Therapeutics Inc.7月14日成交额为137.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551413760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551413760?lang=zh_cn&edition=full","pubTime":"2025-07-15 10:14","pubTimestamp":1752545678,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Galectin Therapeutics Inc.成交额为137.18万美元，成交额较昨日增加37.79%，当日成交量为50.95万股。Galectin Therapeutics Inc.于2025年7月14日涨13.55%，报2.85美元，该股过去5个交易日涨32.56%，年初至今涨120.93%，过去60日涨112.69%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-14|137.18万|37.79%|50.95万|#|2025-07-11|99.56万|-7.86%|39.21万|#|2025-07-10|108.05万|89.57%|46.17万|#|2025-07-09|57.00万|30.65%|26.16万|#|2025-07-08|43.63万|-58.91%|20.67万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715101440a44b1dae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715101440a44b1dae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","GALT","BK4539","LENZ"],"gpt_icon":0},{"id":"2550993965","title":"Galectin Therapeutics Inc.7月11日成交额为99.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550993965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550993965?lang=zh_cn&edition=full","pubTime":"2025-07-12 10:11","pubTimestamp":1752286273,"startTime":"0","endTime":"0","summary":"美东时间2025年7月11日，Galectin Therapeutics Inc.成交额为99.56万美元，成交额较昨日减少7.86%，当日成交量为39.21万股。Galectin Therapeutics Inc.于2025年7月11日涨2.45%，报2.51美元，该股过去5个交易日涨15.14%，年初至今涨94.57%，过去60日涨87.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-11|99.56万|-7.86%|39.21万|#|2025-07-10|108.05万|89.57%|46.17万|#|2025-07-09|57.00万|30.65%|26.16万|#|2025-07-08|43.63万|-58.91%|20.67万|#|2025-07-07|106.17万|103.66%|48.70万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712101120a445d93a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712101120a445d93a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GALT","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2548337271","title":"Galectin Therapeutics Inc.7月3日成交额为52.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548337271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548337271?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:10","pubTimestamp":1751595046,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Galectin Therapeutics Inc.成交额为52.13万美元，成交额较昨日减少11.50%，当日成交量为23.95万股。Galectin Therapeutics Inc.于2025年7月3日涨0.46%，报2.18美元，该股过去5个交易日跌7.23%，年初至今涨68.99%，过去60日涨63.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-03|52.13万|-11.50%|23.95万|#|2025-07-02|58.90万|-39.74%|27.20万|#|2025-07-01|97.74万|-5.38%|44.70万|#|2025-06-30|103.30万|-77.52%|45.71万|#|2025-06-27|459.49万|279.56%|194.67万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101049a4ce68ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101049a4ce68ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","GALT","BK4539","BK4007"],"gpt_icon":0},{"id":"2546735987","title":"Galectin Therapeutics Inc.6月27日成交额为459.49万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546735987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546735987?lang=zh_cn&edition=full","pubTime":"2025-06-28 10:09","pubTimestamp":1751076542,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Galectin Therapeutics Inc.成交额为459.49万美元，成交额较昨日增加279.56%，当日成交量为194.67万股。Galectin Therapeutics Inc.于2025年6月27日跌0.85%，报2.33美元，该股过去5个交易日跌3.72%，年初至今涨80.62%，过去60日涨84.92%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-27|459.49万|279.56%|194.67万|#|2025-06-26|121.06万|63.43%|49.96万|#|2025-06-25|74.07万|-43.30%|29.37万|#|2025-06-24|130.65万|-46.49%|54.57万|#|2025-06-23|244.16万|-78.05%|97.77万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ，在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628100904a721e675&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628100904a721e675&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","GALT","LENZ","BK4007"],"gpt_icon":0},{"id":"2546343837","title":"Galectin Therapeutics Inc.盘中异动 早盘快速拉升5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546343837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546343837?lang=zh_cn&edition=full","pubTime":"2025-06-26 21:51","pubTimestamp":1750945872,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日21时51分，Galectin Therapeutics Inc.股票出现波动，股价急速上涨5.98%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Vor Biopharma Inc.、Adial Pharmaceuticals, Inc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Aspire Biopharma Holdings, Inc.较为活跃，换手率分别为828.40%、204.03%、71.09%，振幅较大的相关个股有Vor Biopharma Inc.、Apollomics Inc C/Wts 01/04/2028 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为77.56%、40.05%、23.02%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626215112952cbe14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626215112952cbe14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","GALT","LENZ","BK4139"],"gpt_icon":0},{"id":"2512571165","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512571165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512571165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889186,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Galectin Therapeutics Inc.股票出现波动，股价快速拉升5.67%。截至发稿，该股报1.49美元/股，成交量12.6519万股，换手率0.20%，振幅3.52%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为279.92%、96.82%、73.20%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.，振幅分别为34.04%、22.30%、18.61%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223306abd3af86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223306abd3af86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GALT"],"gpt_icon":0},{"id":"2505568271","title":"Galectin Therapeutics Inc.盘中异动 大幅下挫5.65%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505568271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505568271?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:32","pubTimestamp":1737469936,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时32分，Galectin Therapeutics Inc.股票出现波动，股价大幅跳水5.65%。截至发稿，该股报1.17美元/股，成交量2.8401万股，换手率0.05%，振幅2.42%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223217960bb911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223217960bb911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","LENZ","BK4139"],"gpt_icon":0},{"id":"2501564702","title":"Galectin Therapeutics Inc.盘中异动 股价大涨6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501564702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501564702?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:32","pubTimestamp":1736173971,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时32分，Galectin Therapeutics Inc.股票出现波动，股价快速上涨6.03%。截至发稿，该股报1.23美元/股，成交量1.4147万股，换手率0.02%，振幅0.86%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Scisparc Ltd.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Cytomed Therapeutics Limited较为活跃，换手率分别为427.87%、206.11%、80.33%，振幅较大的相关个股有Scisparc Ltd.、Renovaro Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为27.45%、16.20%、13.36%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223251aba088d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223251aba088d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","LENZ","BK4139"],"gpt_icon":0},{"id":"2495619898","title":"Galectin Therapeutics Inc.盘中异动 早盘快速上涨5.27%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495619898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495619898?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:30","pubTimestamp":1735655451,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时30分，Galectin Therapeutics Inc.股票出现异动，股价快速拉升5.27%。截至发稿，该股报1.16美元/股，成交量3.8924万股，换手率0.06%，振幅0.91%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为849.65%、617.36%、130.44%，振幅较大的相关个股有Eyenovia, Inc.、Onconetix, Inc.、Portage Biotech Inc.，振幅分别为18.27%、11.44%、10.12%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024123122305295f42d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","GALT","BK4139"],"gpt_icon":0},{"id":"2494394338","title":"HC Wainwright & Co.：下调Galectin Therapeutics(GALT.US)评级，由买入调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2494394338","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494394338?lang=zh_cn&edition=full","pubTime":"2024-12-28 00:51","pubTimestamp":1735318314,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：下调Galectin Therapeutics(GALT.US)评级，由买入调整至中性评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/28005146909277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","GALT"],"gpt_icon":0},{"id":"2494338598","title":"Galectin Therapeutics Inc.盘中异动 股价大涨5.28%报0.916美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494338598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494338598?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:31","pubTimestamp":1735309896,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时31分，Galectin Therapeutics Inc.股票出现波动，股价急速上涨5.28%。截至发稿，该股报0.916美元/股，成交量1.5589万股，换手率0.02%，振幅1.03%。Galectin Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Evaxion Biotech As、Vor Biopharma Inc.涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Nucana Plc较为活跃，换手率分别为69.62%、26.31%、14.49%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Evaxion Biotech As、Alumis Inc.，振幅分别为38.73%、20.04%、12.84%。Galectin Therapeutics Inc.公司简介：Galectin Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227223136a20bfdee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227223136a20bfdee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GALT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.galectintherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.2992},{"period":"1month","weight":-0.2369},{"period":"3month","weight":-0.0875},{"period":"6month","weight":0.8099},{"period":"1year","weight":1.19},{"period":"ytd","weight":2.3953}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Galectin Therapeutics Inc.成立于2000年7月作为临制药公司，是一个发展阶段的公司，从事药物开发来为癌症和纤维化疾病创造新的疗法。格拉克缇的候选药物是基于针对半乳糖凝集素蛋白质的方法，这是生物学和病理功能的关键介质。格拉克缇采用天然存在的，随时可用的植物材料为原料，在生产过程中创造具有特定分子量和药物特性的专有复合碳水化合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.098495},{"month":2,"riseRate":0.692308,"avgChangeRate":0.193749},{"month":3,"riseRate":0.461538,"avgChangeRate":0.013797},{"month":4,"riseRate":0.428571,"avgChangeRate":0.091456},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.039749},{"month":6,"riseRate":0.642857,"avgChangeRate":0.041561},{"month":7,"riseRate":0.5,"avgChangeRate":0.060871},{"month":8,"riseRate":0.642857,"avgChangeRate":0.060015},{"month":9,"riseRate":0.571429,"avgChangeRate":0.009696},{"month":10,"riseRate":0.5,"avgChangeRate":-0.023176},{"month":11,"riseRate":0.357143,"avgChangeRate":-0.053714},{"month":12,"riseRate":0.214286,"avgChangeRate":-0.107518}],"exchange":"NASDAQ","name":"Galectin Therapeutics Inc","nameEN":"Galectin Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galectin Therapeutics Inc(GALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Galectin Therapeutics Inc(GALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Galectin Therapeutics Inc,GALT,Galectin Therapeutics Inc股票,Galectin Therapeutics Inc股票老虎,Galectin Therapeutics Inc股票老虎国际,Galectin Therapeutics Inc行情,Galectin Therapeutics Inc股票行情,Galectin Therapeutics Inc股价,Galectin Therapeutics Inc股市,Galectin Therapeutics Inc股票价格,Galectin Therapeutics Inc股票交易,Galectin Therapeutics Inc股票购买,Galectin Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galectin Therapeutics Inc(GALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Galectin Therapeutics Inc(GALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}